Amit Phansalkar
Vorstandsvorsitzender bei Netra, Inc.
Profil
Amit Phansalkar is the founder of Netra, Inc. Prior to founding Netra, he worked as a Principal at Cytel, Inc. and Prolexys Pharmaceuticals, Inc. He also served as Vice President-Product Strategy at Cognika Corp.
Mr. Phansalkar received his undergraduate and graduate degrees from The University of New Mexico.
Aktive Positionen von Amit Phansalkar
| Unternehmen | Position | Beginn |
|---|---|---|
Netra, Inc.
 Netra, Inc. Packaged SoftwareTechnology Services Netra, Inc. provides user-generated video hosting services. The company was founded by Shashi Kant and Amit Phansalkar in 2013 and is headquartered in Boston, MA. | Vorstandsvorsitzender | 01.01.2018 |
Ehemalige bekannte Positionen von Amit Phansalkar
| Unternehmen | Position | Ende |
|---|---|---|
Cytel, Inc.
 Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Prolexys Pharmaceuticals, Inc.
 Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Corporate Officer/Principal | - |
Cognika Corp.
 Cognika Corp. Packaged SoftwareTechnology Services Cognika Corp. provides analytics software solutions. The company is headquartered in Brookline, MA. | Corporate Officer/Principal | - |
Ausbildung von Amit Phansalkar
| The University of New Mexico | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cognika Corp.
Cognika Corp. Packaged SoftwareTechnology Services Cognika Corp. provides analytics software solutions. The company is headquartered in Brookline, MA. | Technology Services |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA. | Technology Services |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Netra, Inc.
Netra, Inc. Packaged SoftwareTechnology Services Netra, Inc. provides user-generated video hosting services. The company was founded by Shashi Kant and Amit Phansalkar in 2013 and is headquartered in Boston, MA. | Technology Services |
